Keywords
KIAA1363; Serine Hydrolase; Fluorescence imagingActivity-based protein profiling (ABPP) is a chemical proteomic platform for characterizing enzyme activities in native biological systems. [1][2][3] Original small-molecule probes for ABPP were designed to target large numbers of enzymes that share mechanistic and/or structural features. These efforts have yieled activity-based probes for many enzyme classes, including serine [4][5] and cysteine [6] hydrolases,oxidoreductases, [7] metalloproteases, [8] histone deacetylases, [9] kinases, [10] and glycosidases. [11][12] ABPP has been applied to discover enzyme activities that are deregulated in biological processes such as cancer [13] and infectious disease [14] . Configuring ABPP to operate in a competitive mode has further enabled the development of selective inhibitors to probe the function of disease-relevant enzymes in cell and animal models. [5][6][15] As biological studies using ABPP have evolved, the need for target-selective activity-based probes has also become apparent. The specificity of such probes opens up new biological applications, including direct spatial and temporal visualization of active enzymes in cells and tissues. [16][17] While attractive in principle, the development of protein-selective, activity-based imaging probes poses substantial technical challenges. Such a probe should ideally possess several features, including high selectivity for a single enzyme target, a reporter tag for imaging the probe-labeled enzyme, and suitable cell permeability and pharmacokinetic properties for in vivo studies. These objectives have, so far, been realized for only a handful of probes that label proteolytic enzymes [18] and whether they can be achieved for probes that target additional types of enzymes remains unknown.We recently used competitive ABPP to develop potent and selective covalent carbamate inhibitors for the integral membrane serine hydrolase KIAA1363 [19] (also known as AADACL1 or NCEH1), which is highly expressed in aggressive human cancer cell lines and primary tumors. [19][20][21][22] In cancer cells, KIAA1363 regulates a set of pro-tumorigenic ether lipids and disruption of this metabolic pathway with the KIAA1363 inhibitor JW480 impairs cancer cell migration and tumor growth in vivo. [19] Here we have asked whether carbamate inhibitors could be converted into selective chemical probes for spatial and temporal imaging of KIAA1363 activity in cancer cells. There is a particular need for [**] We would like to thank A. Adibekian and the Cravatt lab for insightful discussions and W. Kiosses and the TSRI Microscopy